Cleared Special

K183638 - SmartLinx Vitals Plus Patient Monitorin...

K183638 is the FDA 510(k) clearance for SmartLinx Vitals Plus Patient Monitorin... by Capsule Technologie. It is a Class 2 Cardiovascular device (product code MWI) cleared through the Special 510(k) pathway after a 112-day FDA review.

K183638 · Capsule Technologie · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Apr 2019
Decision
112d
Days
Class 2
Risk

K183638 is an FDA 510(k) clearance for the SmartLinx Vitals Plus Patient Monitoring System. Classified as Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms) (product code MWI), Class II - Special Controls.

Submitted by Capsule Technologie (Andover, US). The FDA issued a Cleared decision on April 17, 2019 after a review of 112 days - within the typical 510(k) review window.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2300 - the FDA cardiovascular device oversight framework. As a Special 510(k), this submission covers a manufacturer modification to an existing cleared device rather than a new device introduction.

Device pattern: Iterative device modification. Standard predicate reliance. This Special 510(k) clearance confirms that the manufacturer's modifications remained within the established regulatory envelope of the original cleared device.

View all Capsule Technologie devices

Submission Details

510(k) Number K183638 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received December 26, 2018
Decision Date April 17, 2019
Days to Decision 112 days
Submission Type Special
Review Panel Cardiovascular (CV)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
13d faster than avg
Panel avg: 125d · This submission: 112d
Pathway characteristics
Modification to existing cleared device.

Device Classification

Product Code MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 870.2300
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Cardiovascular devices follow this clearance model.

Regulatory Peers - MWI Monitor, Physiological, Patient (without Arrhythmia Detection Or Alarms)

All 123
Devices cleared under the same product code (MWI) and FDA review panel - the closest regulatory comparables to K183638.
Nihon Kohden SVM-7200 Series Vital Signs Monitor
K190468 · Nihon Kohden Corporation · May 2019
Masimo Rad-97 and Accessories
K183697 · Masimo Corporation · May 2019
Stasis Monitoring System
K183634 · Stasis Labs, Inc. · Apr 2019
Connect App for iHealth Next, iHealth React Native SDK, iHealth React Native Library SDK, iHealth Library SDK, iHealth Native SDK
K181541 · Andon Health Co, Ltd. · Apr 2019
Patient Monitor
K181919 · Guangdong Biolight Meditech Co., Ltd. · Apr 2019
3880 MRI Patient Monitoring System
K180903 · Iradimed Corporation · Mar 2019